Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.63624 | 96 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.58112 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.92304 | 96 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.2136 | 94 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 9.11958 | 96 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.61696 | 93 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.26547 | 91 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.24574 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.58499 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 9.04347 | 96 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.72443 | 96 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 9.19187 | 97 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 9.20163 | 97 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 9.0003 | 96 |